◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › OSCR

Oscar Health, Inc. (OSCR) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Healthcare Plans · DATA UPDATED 2026-07-21

Oscar Health, Inc. (OSCR) operates in the Healthcare Plans industry and is headquartered in New York, United States with about 2,305 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, OSCR reported $11.7B in revenue and ($443M) in net income.

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets.

Interactive charts & full statements → Open the OSCR valuation workbench →

OSCR Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$11.7B$9.2B$5.9B$4.1B
Net Income($443M)$25M($271M)($606M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OSCR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$4.6B$2.8B$3.0B$2.9B$3.0B
Net Income$679M($353M)($137M)($228M)$275M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OSCR Free Cash Flow History

OSCR Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$6.3B$4.8B$3.6B$4.5B
Total Liabilities$5.3B$3.8B$2.8B$3.6B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OSCR viewer.

Other Companies in Healthcare Plans

← OSBCAll stocksOSG →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.